ADVANCED Pharmacy Australia (AdPha) has launched ObesiD, Australia's first drug dosing guideline for obesity, which will be delivered via a new partnership with Therapeutic Guidelines.
"As an increasing number of Australians live with overweight or obesity, it is important to consider how to optimise medication dosing and outcomes in this cohort," said AdPha ObesiD working party member Jeanie Misko.
"ObesiD, created by a hardworking team of pharmacists and experts, will offer concise, evidence-based information on dosing for many common medications."
The resource will be available on both desktop and mobile, giving pharmacists and other health professionals ready access to trusted, evidence-based guidance.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Dec 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Dec 25
